Drugs / CBD
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT03537950 | Aug 2016 → Feb 2017 | autism spectrum disorder | King's College London | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CBD | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03537950 ↗ |
| Route | Oral | “Single oral dose of cannabidiol (CBD) - 600mg.” NCT03537950 ↗ |